Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Moderna, Inc.    MRNA

MODERNA, INC.

(MRNA)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector newsMarketScreener StrategiesAnalyst Recommendations

Moderna : Euro zone government bond yields tick up, German inflation falls

11/30/2020 | 05:16am EST

* Euro zone periphery govt bond yields http://tmsnrt.rs/2ii2Bqr

LONDON, Nov 30 (Reuters) - Euro zone government bond yields ticked up on Monday as traders mostly ignored Moderna's application for U.S. and EU emergency use for its COVID-19 vaccine and focused on the next moves of the European Central Bank to fight low inflation.

German annual consumer prices fell further in November, pushed down by a VAT cut introduced as part of the government's stimulus push to help Europe's largest economy recover from the coronavirus shock.

Consumer prices fell 0.7% year-on-year after shrinking by 0.5% in the previous month, the Federal Statistics Office said.

ECB members last week warned about the risks of tolerating a long period of weak inflation.

Germany's 10-year Bund yield was up about 2 bps at -0.570%, after reaching -0.598%, its lowest since Nov. 9.

In the peripheral markets, Italian 10-year BTP inched up at 0.584% after briefly touching a record low 0.551%.

The spread between German and Italian yields - essentially the premium Italy pays for its debt - was close to its narrowest for this year, last at 114.9 bps.

Portuguese 10-year government bond yields moved further away from zero, last trading at 0.034%. They got close to zero last week, and on some trading platforms broke into negative territory.

"The market tone will continue to be determined by the uneasy balance between hopes of a longer-term resumption of normal activity as vaccines are rolled out and a nearer-term realisation as to the damage currently being caused by the virus," said Lyn Graham-Taylor, fixed income strategist at Rabobank.

This week, Germany and France will be tapping the euro zone bond market, according to Rabobank.

Investors will also be looking for the U.S. November jobs report and the ISM indices this week, but ING analysts said that "given lockdowns and curfews kicking in, especially the jobs data, could be old news already".

"Sentiment will likely be driven more by the potentially accelerated COVID dynamics after Thanksgiving gatherings," ING analysts said. (Reporting by Olga Cotaga; additional reporting by Julien Ponthus; editing by Larry King and Steve Orlofsky)


© Reuters 2020
All news about MODERNA, INC.
03:57pMODERNA : Vaccination campaign gets underway in nine Cree communities in norther..
AQ
03:55aSwiss to get Moderna vaccine in tranches until mid-year - Blick
RE
01/16MODERNA : U.S. COVID-19 vaccine supplies strain to meet wider eligibility, secon..
RE
01/15PFIZER : Anger in states over pace of COVID-19 vaccine allotments
AQ
01/15MODERNA : WHO sees poorer countries getting first COVID vaccines this quarter
RE
01/1531.2 MLN DOSES OF COVID-19 VACCINES : U.s. cdc
RE
01/15COVID-19 VACCINES : Development, Distribution And Dosing
AQ
01/14EXCLUSIVE : India to treat homegrown COVID-19 vaccine same as AstraZeneca's
RE
01/14MODERNA : U.S. big-city mayors ask Biden for direct shipments of COVID-19 vaccin..
RE
01/14UK to step up coronavirus vaccinations -FT
RE
More news
Financials (USD)
Sales 2020 511 M - -
Net income 2020 -566 M - -
Net cash 2020 2 865 M - -
P/E ratio 2020 -108x
Yield 2020 -
Capitalization 51 304 M 51 304 M -
EV / Sales 2020 94,7x
EV / Sales 2021 4,51x
Nbr of Employees 1 100
Free-Float 90,0%
Chart MODERNA, INC.
Duration : Period :
Moderna, Inc. Technical Analysis Chart | MRNA | US60770K1079 | MarketScreener
Technical analysis trends MODERNA, INC.
Short TermMid-TermLong Term
TrendsBearishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 16
Average target price 136,60 $
Last Close Price 129,65 $
Spread / Highest target 42,7%
Spread / Average Target 5,36%
Spread / Lowest Target -46,8%
EPS Revisions
Managers and Directors
NameTitle
Stéphane Bancel Chief Executive Officer & Director
Stephen Hoge President
Noubar B. Afeyan Chairman
David W. Meline Chief Financial Officer
Juan Andres Chief Technical Operations & Quality Officer
Sector and Competitors
1st jan.Capitalization (M$)
MODERNA, INC.24.10%51 304
LONZA GROUP AG3.27%49 041
CELLTRION, INC.-8.36%40 715
IQVIA HOLDINGS INC.4.81%36 004
SEAGEN INC.6.06%33 601
HANGZHOU TIGERMED CONSULTING CO.,LTD0.37%21 655